Targeted Therapies in Cancer: Myth or Reality? /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Advances in Experimental Medicine and Biology,
610 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-0-387-73898-7 |
Tabla de Contenidos:
- Causality in Medicine
- The Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy
- Anticancer Drug Discovery and Development
- Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms
- Aurora Kinases and Their Inhibitors: More Than One Target and One Drug
- Signalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors
- Developing T-Cell Therapies for Cancer in an Academic Setting
- Anticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells
- Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies
- Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned?
- GIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design
- Monoclonal Antibodies in the Treatment of Malignant Lymphomas
- Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy.